Global, regional and national temporal trends in prevalence for musculoskeletal disorders in women of childbearing age, 1990–2019: an age-period-cohort analysis based on the Global Burden of Disease Study 2019Fan Cao, Da-Peng Li, Guo-Cui Wu, Yi-Sheng He, Yu-Chen Liu, Jing-Jing Hou, Qin-Yu Ni, Li-Ming Tao, Zheng-Xuan Jiang, Hai-Feng Pan
4 September 2023
Is colchicine prophylaxis required with start-low go-slow allopurinol dose escalation in gout? A non-inferiority randomised double-blind placebo-controlled trialLisa Stamp, Anne Horne, Borislav Mihov, Jill Drake, Janine Haslett, Peter T Chapman, Christopher Frampton, Nicola Dalbeth
31 August 2023
Dupilumab for relapsing or refractory sinonasal and/or asthma manifestations in eosinophilic granulomatosis with polyangiitis: a European retrospective studyBerengere Molina, Roberto Padoan, Maria Letizia Urban, Pavel Novikov, Marco Caminati, Camille Taillé, Antoine Néel, Laurence Bouillet, Paolo Fraticelli, Nicolas Schleinitz, Christine Christides, Laura Moi, Bertrand Godeau, Ann Knight, Jan Walter SchroederSee the full list of authors
21 September 2023
Time and dose-dependent effect of systemic glucocorticoids on major adverse cardiovascular event in patients with rheumatoid arthritis: a population-based studyHo So, Tsz On Lam, Huan Meng, Steven Ho Man Lam, Lai-Shan Tam
24 July 2023
Effect of tapered versus stable treatment with tumour necrosis factor inhibitors on disease flares in patients with rheumatoid arthritis in remission: a randomised, open label, non-inferiority trialSiri Lillegraven, Nina Paulshus Sundlisæter, Anna-Birgitte Aga, Joseph Sexton, Inge Christoffer Olsen, Åse Stavland Lexberg, Tor Magne Madland, Hallvard Fremstad, Christian A. Høili, Gunnstein Bakland, Cristina Spada, Hilde Haukeland, Inger Myrnes Hansen, Ellen Moholt, Till UhligSee the full list of authors
22 August 2023
Budget impact analysis and treatment availability with biosimilar TNF inhibitors in rheumatic diseases in Poland: real-world evidence using a nationwide databaseMarcin Stajszczyk, Izabela Obarska, Slawomir Jeka, Bogdan Batko
16 June 2023
Approach to vaccination in systemic lupus erythematosus on biological treatmentReşit Yıldırım, Tatiana Oliveira, David Alan Isenberg
19 June 2023
Is methotrexate safe for men with an immune-mediated inflammatory disease and an active desire to become a father? Results of a prospective cohort study (iFAME-MTX)Luis Fernando Perez-Garcia, Esther Röder, Bouwe P Krijthe, Laura JC Kranenburg-van Koppen, Roxanne van Adrichem, Els Zirkzee, Pieter H Griffioen, Kris Peeters, Marry Lin, Eduard A Struys, Gerrit Jansen, Martijn BA van Doorn, Robert de Jonge, Gert R Dohle, Radboud JEM Dolhain
1 June 2023
JAK inhibitors and the risk of malignancy: a meta-analysis across disease indicationsMark D Russell, Christopher Stovin, Edward Alveyn, Olukemi Adeyemi, Chun Kit David Chan, Vishit Patel, Maryam A Adas, Fabiola Atzeni, Kenrick K H Ng, Andrew I Rutherford, Sam Norton, Andrew P Cope, James B Galloway
29 May 2023
Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled trialRona M Smith, Rachel B Jones, Ulrich Specks, Simon Bond, Marianna Nodale, Reem Al-jayyousi, Jacqueline Andrews, Annette Bruchfeld, Brian Camilleri, Simon Carette, Chee Kay Cheung, Vimal Derebail, Tim Doulton, Alastair Ferraro, Lindsy ForbessSee the full list of authors
23 March 2023